LGM
NERV icon

Logos Global Management’s Minerva Neurosciences NERV Stock Holding History

Logos Global Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4M Sell
3,215,000
-96,000
-3% -$551K 0.97% 34
2025
Q4 		$13.3M Buy
+3,311,000
New +$12.3M 0.8% 38
2020
Q2 		– Sell
-38,718
Closed -$1.86M – 57
2020
Q1 		$1.86M Buy
38,718
+10,239
+36% +$618K 0.71% 38
2019
Q4 		$1.62M Buy
+28,479
New +$1.26M 0.4% 37

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Logos Global Management's NERV Position: Q1 2026 in Review

Logos Global Management reduced its Minerva Neurosciences (NERV) stake by 2.9% in Q1 2026, selling an estimated $551K and leaving 3,215,000 shares worth $19.4M. The position accounts for 0.97% of the portfolio, ranked #34.

Logos Global Management first reported a position in NERV in Q4 2019 and has held it in 4 quarters since. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Logos Global Management held 3,215,000 shares of Minerva Neurosciences worth $19.4M as of Q1 2026.
  • Logos Global Management sold 96,000 Minerva Neurosciences shares in Q1 2026, an estimated $551K.
  • Minerva Neurosciences made up 0.97% of Logos Global Management's portfolio in Q1 2026, its #34 holding.
  • Logos Global Management first reported a position in Minerva Neurosciences in Q4 2019 and has held it in 4 quarters since.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.